Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Nov. 12, 2013, 237 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $356,344,136.36. Highlighted Stocks Traded by Insiders: Medical Properties (MPW) - FREE Research Report Hamner R Steven who is EVP and CFO at Medical Properties sold 100,000 shares at $13.00 on Nov. 12, 2013. Following this transaction, the EVP and CFO owned 1.0 million shares meaning that the stake was reduced by 8.74% with the 100,000 share transaction. The shares most recently traded at $12.70, down $0.30, or 2.36% since the insider transaction. The average volume for Medical Properties has been 1.3 million shares per day over the past 30 days. Medical Properties has a market cap of $2.1 billion and is part of the financial sector and real estate industry. Shares are up 7.27% year to date as of the close of trading on Tuesday. Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers. The stock currently has a dividend yield of 6.55%. The company has a P/E ratio of 18.6. Currently there is 1 analyst that rates Medical Properties a buy, 2 analysts rate it a sell, and 6 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on MPW - FREE TheStreet Quant Ratings rates Medical Properties as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Medical Properties Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
